SCHEMBL3963536

SCHEMBL3963536

CC(C)(C)c1cc(NC(=O)C(C)(C)S(=O)(=O)c2cccc(C(F)(F)F)c2)no1.CC(C)(C)c1cc(NC(=O)C(C)(C)S(=O)(=O)c2ccccc2)no1.CC(C)(C)c1csc(NC(=O)C(C)(C)S(=O)(=O)c2cccc(C(F)(F)F)c2)n1.CC(C)(C)c1csc(NC(=O)C(C)(C)S(=O)(=O)c2ccccc2)n1.Cc1nc(C(N)=O)sc1C(C)(C)C.O=C(O)C1(S(=O)(=O)c2ccc(Cl)cc2)CCC1

nearest known ligand 0.44

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 11/20 0.44
CNR1 P21554 6/20 0.44
KDM1A O60341 1/20 0.32
MAPT P10636 5/20 0.32
KDM4E B2RXH2 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
MEN1 O00255 2/20 0.30
KMT2A Q03164 2/20 0.30
GAA P10253 1/20 0.30
TSHR P16473 1/20 0.30
MAPK1 P28482 1/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3966620 0.92 CNR2 (0.52) CNR2CNR1KDM1AMAPTKDM4E
SCHEMBL3962999 0.91 CNR2 (0.51) CNR2CNR1KDM1AMAPTKDM4E
SCHEMBL3965017 0.84 CNR2 (0.49) CNR2CNR1MAPTKDM4ENPSR1
SCHEMBL3964901 0.84 CNR2 (0.52) CNR2CNR1KDM1AMAPTKDM4E
SCHEMBL3959609 0.84 CNR2 (0.40) CNR2CNR1
SCHEMBL3959616 0.78 CNR2 (0.41) CNR2CNR1KDM1A
SCHEMBL3965021 0.77 CNR2 (0.50) CNR2CNR1MAPTKDM4ENPSR1
SCHEMBL3959680 0.77 CNR2 (0.38) CNR2CNR1MAPT
SCHEMBL3962941 0.74 CNR2 (0.51) CNR2CNR1MAPTKMT2AGAA
SCHEMBL3959810 0.73 CNR2 (0.58) CNR2CNR1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2081905-A2 SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR Boehringer Ingelheim International GmbH (DE) 2009-07-29 EP disclosed
WO-2008014199-A2 SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-01-31 WO disclosed